A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer - Schneeweiss, Andreas; Marmé, Frederik; Ruiz, A.; Manikhas, A. G.; Bottini, A.; Wolf, M.; Sinn, Peter; Mansouri, K.; Kennedy, L.; Bauknecht, T. (Annals of oncology, 2011)
Gesehen am 12.10.2022